An increase in orosomucoid 2, differentially expressed in both plasma and CSF of patients with cerebral malaria, together with an increased production of ceruloplasmin and glutathione, would enhance antioxidant defenses and limit the stimulatory effects of oxidant molecules on cytokine production. The gene discussed is ORM2; the disease is cerebral malaria.